ACM
SLNO

AIGH Capital Management’s Soleno Therapeutics SLNO Stock Holding History

AIGH Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-364,306
Closed -$1.56M – 54
2023
Q2 		$1.56M Sell
364,306
-58,183
-14% -$250K 0.64% 34
2023
Q1 		$904K Hold
422,489
– – 0.33% 46
2022
Q4 		$837K Sell
422,489
-1,600
-0.4% -$1.99K 0.28% 41
2022
Q3 		$708K Sell
424,089
-1
-0% -$2 0.22% 39
2022
Q2 		$1.18M Sell
424,090
-29,243
-6% -$81K 0.31% 34
2022
Q1 		$1.52M Buy
+453,333
New +$2.35M 0.37% 33

Other funds holding SLNO

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

AIGH Capital Management's SLNO Position: Q3 2023 in Review

AIGH Capital Management sold out of Soleno Therapeutics (SLNO) in Q3 2023, closing a stake of 364,306 shares — an estimated $1.56M sold.

AIGH Capital Management first reported a position in SLNO in Q1 2022 and held it in 6 quarters. The position peaked at $1.56M in Q2 2023. 54 funds tracked by Wall St. Rank hold SLNO as of Q3 2023.

  • AIGH Capital Management reported no remaining Soleno Therapeutics position as of Q3 2023 after selling out during the quarter.
  • AIGH Capital Management sold 364,306 Soleno Therapeutics shares in Q3 2023, an estimated $1.56M.
  • AIGH Capital Management first reported a position in Soleno Therapeutics in Q1 2022 and held it in 6 quarters.
  • AIGH Capital Management's Soleno Therapeutics position peaked at $1.56M in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2023.

Based on AIGH Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.